Hypoactive sexual desire disorder (HSDD) refers to a woman’s chronic or ongoing lack of interest in sex, to the point that it causes her personal distress or problems in her relationships.
To evaluate the efficacy and safety of subcutaneously administered Bremelanotide (BMT) in pre-menopausal Women with Hypoactive Sexual Desire Disorder (HSDD).